Lessons from a French collaborative case–control study in cystic fibrosis patients during the 2009 A/H1N1 influenza pandemy
(1)
,
(2)
,
(3, 4)
,
(1)
,
(5)
,
(6)
,
(7)
,
(8)
,
(9)
,
(10, 11)
,
(12)
,
(13)
,
(14)
,
,
,
(15)
,
(16, 17)
,
(18)
,
(19, 20)
,
(21)
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
Pierre-Yves Boëlle
- Function : Author
- PersonId : 172531
- IdHAL : pierre-yves-boelle
- ORCID : 0000-0002-5367-8232
- IdRef : 103665730
Dominique Hubert
- Function : Author
- PersonId : 957568
Bertrand Delaisi
- Function : Author
- PersonId : 938752
Harriet Corvol
- Function : Author
- PersonId : 982684
- IdHAL : harriet-corvol
- ORCID : 0000-0002-7026-7523
- IdRef : 05978833X
Marie Véronique Vodoff
- Function : Author
Véronique Boussaud
- Function : Author
Jean-Marc Tréluyer
- Function : Author
- PersonId : 952433
Odile Launay
- Function : Author
- PersonId : 764764
- ORCID : 0000-0003-3242-7247
Abstract
Viral infections such as influenza are thought to impact respiratory parameters and to promote infection with Pseudomonas aeruginosa in patients with cystic fibrosis (CF). However, the real morbidity of the influenza virus in CF needs to be further investigated because previous studies were only observational